Economy

Teva Pharmaceutical Industries Limited (TEVA) Cut to "Strong Sell" at BidaskClub

Teva Pharma had 91 analyst reports since July 21, 2015 according to SRatingsIntel.

Teva Pharmaceutical Industries Limited is maintained at an average hold rating by 26 stock analysts, and there are at least 5.01% of shares outstanding that are now legally short sold.

Covering sell-side analysts have recently weighed in on shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA). (The) reiterated a "neutral" rating and issued a $21.00 price target (down previously from $28.00) on shares of Teva Pharmaceutical Industries Limited in a research report on Thursday, August 31st.

Michael Price increased its stake in Teva Pharmaceutical Industries Ltd. (TEVA) by 48.41% based on its latest 2016Q4 regulatory filing with the SEC. Finally, Vetr upgraded Teva Pharmaceutical Industries Limited from a "hold" rating to a "buy" rating and set a $34.17 price target on the stock in a report on Monday, July 24th. The company presently has an average rating of "Hold" and a consensus price target of $31.20. Teva Pharmaceutical Industries Limited also was the recipient of unusually large options trading on Monday.

The difference of 52 week low value as well as 52 week high value and the current price of the stock suggests the next move of the shares. Teva Pharmaceutical Industries Limited has a one year low of $15.22 and a one year high of $51.51. Price Michael F who had been investing in Teva Pharmaceutical Industries Ltd. for a number of months, seems to be bullish on the $17.42B market cap company.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) last issued its earnings results on Thursday, August 3rd. The firm had revenue of $5.69 billion for the quarter, compared to analyst estimates of $5.72 billion. During the same quarter in the prior year, the firm posted $1.25 earnings per share. Teva Pharmaceutical Industries Limited had a negative net margin of 25.18% and a positive return on equity of 15.96%. If the share price is now hovering near the 52 week low and the value is achieved in the current past then it can suggest that the price of the shares is likely to go up.

The company also recently announced a quarterly dividend, which was paid on Thursday, September 14th. Shareholders of record on Tuesday, August 29th were issued a dividend of $0.085 per share. The rating was downgraded by Credit Suisse to "Neutral" on Friday, August 4. This represents a $0.34 annualized dividend and a yield of 1.98%. Teva Pharmaceutical Industries Limited's payout ratio is now -15.36%.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. The company reported $0.99 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $1.06 by ($0.07). Sii Investments Inc. WI now owns 6,739 shares of the company's stock valued at $214,000 after purchasing an additional 25 shares during the last quarter. Northwestern Mutual Wealth Management Co. now owns 21,678 shares of the company's stock worth $695,000 after purchasing an additional 2,322 shares during the last quarter. Capital Research Global Investors boosted its position in shares of Teva Pharmaceutical Industries Limited by 13.8% in the second quarter. Airain ltd now owns 656,894 shares of the company's stock worth $21,080,000 after purchasing an additional 124,232 shares during the last quarter. Airain ltd lifted its stake in Teva Pharmaceutical Industries Limited by 23.3% during the first quarter. Northern Cross LLC lifted its stake in Teva Pharmaceutical Industries Limited by 14.0% in the 2nd quarter. Nordea Investment Management AB now owns 12,884,810 shares of the company's stock valued at $428,033,000 after purchasing an additional 311,894 shares during the last quarter.

TRADEMARK VIOLATION WARNING: "Investors Purchase High Volume of Teva Pharmaceutical Industries Limited Put Options (TEVA)" was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another domain, it was illegally copied and republished in violation of United States & worldwide copyright laws. The original version of this article can be read at https://weekherald.com/2017/09/21/cantor-fitzgerald-analysts-give-teva-pharmaceutical-industries-limited-teva-a-17-00-price-target.html.



Like this

Latest


22 September 2017
Leidos Holdings, Inc. (LDOS) Holdings Lifted by FIL Ltd
Finally, DekaBank Deutsche Girozentrale purchased a new stake in shares of Leidos Holdings in the 1st quarter valued at $247,000. TRADEMARK VIOLATION WARNING: This report was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal.

22 September 2017
United Natural Foods, Inc. (NASDAQ:UNFI) Experiences Heavy Trading Volume
The stock has actually made strong gains in the past year, as the company has gathered a 0.46% return in the past twelve months. Kiltearn Partners LLP purchased a new stake in shares of United Natural Foods in the 2nd quarter worth about $74,701,000.

22 September 2017
Bankrupt Toys R Us Is Hiring For The Holidays
News reports earlier this month speculating that the company may be going bankrupt made business partners nervous. This is extremely important for the company as a whole because of the upcoming holiday season.

22 September 2017
Monsanto Company (MON) EPS Estimated At $
The basic materials company reported $1.93 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.74 by $0.19. Acrospire Investment Management LLC purchased a new stake in shares of Monsanto during the 1st quarter valued at about $113,000.

22 September 2017
Video shows helicopter rescue from capsized vessel after Hurricane Maria
Big waves caused by Jose swept five people off a coastal jetty in Rhode Island and they were hospitalized after being rescued. This year's Irma, which had 185 miles per hour (300 kph) winds, ranks second.

22 September 2017
Traders Buy Shares of Regeneron Pharmaceuticals, Inc. (REGN) on Weakness
The biopharmaceutical company reported $4.17 earnings per share for the quarter, topping the consensus estimate of $2.67 by $1.50. North Point Portfolio Managers Corp increased Regeneron Pharmaceuticals (REGN) stake by 2.59% reported in 2017Q2 SEC filing.

22 September 2017
Woman raped, robbed by man who offered to walk her home
The public can also submit tips on the Crime Stoppers website or by texting them to 274637 (CRIMES) then entering TIP577. While they walked through Central Park, he pulled a knife, then raped and physically assaulted her, police said.

22 September 2017
Man Utd and Chelsea face legal threat over disabled standards
How good is David now? "We are pleased [the matter] has been resolved and wish him a successful future". But I think because of the money they have spent they are the favorites.

22 September 2017
Bank Of Nova Scotia (The) (NYSE:BNS) Under Analyst Spotlight
Seekingalpha.com's article titled: "Position Update: Tenneco" and published on August 30, 2017 is yet another important article. RBC Capital Markets maintained Bank of Nova Scotia (NYSE:BNS) on Wednesday, August 31 with "Outperform" rating.

22 September 2017
Trump Gave Me 'Handsy,' 'Pornographic' Hugs — MSNBC's Mika
Brzezinski covered her mouth as if she was going to become physically ill and said, "This is real". But Brzezinski at first responded, "kinda", then clarified: "It's handsy ".



Recommended